Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Chemoresistance in Patients Treated for Gestational Trophoblastic Tumors

NCT03488901 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03488901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03488901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Chemoresistance in Patients Treated for Gestational Trophoblastic Tumors
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2018
Completion date
December 31, 2018
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trophoblastic tumor